{
    "10.1001_jamacardio.2018.1579": {
        "content": "{\n    \"Baseline_Characteristics\": {\n        \"Age\": 71,\n        \"Sex\": \"Male\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": \"N/A\",\n        \"Hyperlipidemia\": true,\n        \"Coronary artery disease\": true,\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"N/A\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": true,\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": true,\n        \"Anticoagulant\": true,\n        \"Statins\": true,\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": \"N/A\",\n        \"Coronary artery bypass grafting (CABG)\": \"N/A\",\n        \"Society of Thoracic Surgeons (STS) Score\": \"N/A\",\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": 55\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum pressure gradient (PG)\": 14,\n        \"Mean PG\": 29,\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA Index\": \"N/A\",\n        \"≥ Moderate aortic regurgitation\": \"N/A\",\n        \"≥ Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Average annular diameter\": \"N/A\",\n        \"Minimum annular diameter\": \"N/A\",\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": \"N/A\",\n        \"Transapical approach\": \"N/A\",\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size\": \"N/A\",\n        \"THV size ≥ 26 mm\": \"N/A\",\n        \"THVtype (Self-expandable valve/Balloon-expandable valve)\": \"Balloon-expandable\",\n        \"Pre-dilation\": \"N/A\",\n        \"Post-dilation\": \"N/A\",\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": \"N/A\",\n        \"Mal-positioning\": \"N/A\",\n        \"Annular rupture\": \"N/A\",\n        \"Excessive oversizing\": \"N/A\",\n        \"Excessive oversizing ≥ 15%\": \"N/A\",\n        \"if Immediate post-procedural paravalvular leakage (PVL)\": \"N/A\",\n        \"PVL severity\": \"N/A\",\n        \"THV displacement\": \"N/A\",\n        \"Conversion to surgical aortic valve replacement\": \"N/A\",\n        \"Conversion to Cardiopulmonary bypass (CPB)\": \"N/A\",\n        \"Valve-in-valve\": \"N/A\",\n        \"Periprocedural death\": \"N/A\"\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death before discharge\": \"N/A\",\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": \"N/A\",\n        \"Life-threatening bleeding\": \"N/A\",\n        \"Acute kidney injury\": \"N/A\",\n        \"Major vascular complication\": \"N/A\",\n        \"New-onset permanent pacemaker implantation\": \"N/A\",\n        \"if PVL before discharge\": \"N/A\",\n        \"PVL severity\": \"N/A\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30-day all-cause mortality\": \"N/A\",\n        \"30-day myocardial infarction\": \"N/A\",\n        \"30-day stroke\": \"N/A\",\n        \"30-day heart failure readmission\": \"N/A\",\n        \"1-year all-cause mortality\": \"N/A\",\n        \"1-year myocardial infarction\": \"N/A\",\n        \"1-year stroke\": \"N/A\",\n        \"1-year heart failure readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": \"N/A\",\n        \"PVL severity\": \"N/A\"\n    }\n}",
        "usage_details": {
            "prompt_tokens": 6273,
            "completion_tokens": 1277,
            "total_tokens": 7550,
            "estimated_cost_usd": 0.00170715
        }
    },
    "10.1001_jamainternmed.2016.9356": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 80,\n        \"Sex\": \"Female\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": \"N/A\",\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": \"N/A\",\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": true,\n        \"New York Heart Association (NYHA) Classification\": \"N/A\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": true,\n        \"Calcium ion blocker\": true,\n        \"Diuretic\": true,\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": true,\n        \"Statins\": true,\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": \"N/A\",\n        \"Coronary artery bypass grafting (CABG)\": \"N/A\",\n        \"Society of Thoracic Surgeons (STS) Score\": \"N/A\",\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum pressure gradient (PG)\": \"12 mmHg\",\n        \"Mean PG\": \"5 mmHg\",\n        \"Effective orifice area (EOA)\": \"1.4 cm²\",\n        \"EOA Index\": \"N/A\",\n        \"≥ Moderate aortic regurgitation\": \"N/A\",\n        \"≥ Moderate mitral regurgitation\": true,\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Average annular diameter\": \"N/A\",\n        \"Minimum annular diameter\": \"N/A\",\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": true,\n        \"Transapical approach\": \"N/A\",\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size\": \"N/A\",\n        \"THV size ≥ 26 mm\": \"N/A\",\n        \"THVtype (Self-expandable valve/Balloon-expandable valve)\": \"N/A\",\n        \"Pre-dilation\": \"N/A\",\n        \"Post-dilation\": \"N/A\",\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": \"N/A\",\n        \"Mal-positioning\": \"N/A\",\n        \"Annular rupture\": \"N/A\",\n        \"Excessive oversizing\": \"N/A\",\n        \"Excessive oversizing ≥ 15%\": \"N/A\",\n        \"if Immediate post-procedural paravalvular leakage (PVL)\": \"N/A\",\n        \"PVL severity\": \"N/A\",\n        \"THV displacement\": \"N/A\",\n        \"Conversion to surgical aortic valve replacement\": \"N/A\",\n        \"Conversion to Cardiopulmonary bypass (CPB)\": \"N/A\",\n        \"Valve-in-valve\": \"N/A\",\n        \"Periprocedural death\": \"N/A\"\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death before discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": false,\n        \"Life-threatening bleeding\": false,\n        \"Acute kidney injury\": false,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": false,\n        \"if PVL before discharge\": false,\n        \"PVL severity\": \"N/A\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30-day all-cause mortality\": \"N/A\",\n        \"30-day myocardial infarction\": \"N/A\",\n        \"30-day stroke\": \"N/A\",\n        \"30-day heart failure readmission\": \"N/A\",\n        \"1-year all-cause mortality\": \"N/A\",\n        \"1-year myocardial infarction\": \"N/A\",\n        \"1-year stroke\": \"N/A\",\n        \"1-year heart failure readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": \"N/A\",\n        \"PVL severity\": \"N/A\"\n    }\n}\n```",
        "usage_details": {
            "prompt_tokens": 7311,
            "completion_tokens": 1269,
            "total_tokens": 8580,
            "estimated_cost_usd": 0.00185805
        }
    },
    "10.1001_jamaneurol.2018.1178": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 80,\n        \"Sex\": \"Female\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": \"N/A\",\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": \"N/A\",\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"N/A\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": \"N/A\",\n        \"Coronary artery bypass grafting (CABG)\": \"N/A\",\n        \"Society of Thoracic Surgeons (STS) Score\": \"N/A\",\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum pressure gradient (PG)\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA Index\": \"N/A\",\n        \"≥ Moderate aortic regurgitation\": \"N/A\",\n        \"≥ Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Average annular diameter\": \"N/A\",\n        \"Minimum annular diameter\": \"N/A\",\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": \"N/A\",\n        \"Transapical approach\": \"N/A\",\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size\": \"N/A\",\n        \"THV size ≥ 26 mm\": \"N/A\",\n        \"THVtype (Self-expandable valve/Balloon-expandable valve)\": \"N/A\",\n        \"Pre-dilation\": \"N/A\",\n        \"Post-dilation\": \"N/A\",\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": \"N/A\",\n        \"Mal-positioning\": \"N/A\",\n        \"Annular rupture\": \"N/A\",\n        \"Excessive oversizing\": \"N/A\",\n        \"Excessive oversizing ≥ 15%\": \"N/A\",\n        \"if Immediate post-procedural paravalvular leakage (PVL)\": \"N/A\",\n        \"PVL severity\": \"N/A\",\n        \"THV displacement\": \"N/A\",\n        \"Conversion to surgical aortic valve replacement\": \"N/A\",\n        \"Conversion to Cardiopulmonary bypass (CPB)\": \"N/A\",\n        \"Valve-in-valve\": \"N/A\",\n        \"Periprocedural death\": \"N/A\"\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death before discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": false,\n        \"Life-threatening bleeding\": false,\n        \"Acute kidney injury\": false,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": false,\n        \"if PVL before discharge\": false,\n        \"PVL severity\": \"N/A\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30-day all-cause mortality\": \"N/A\",\n        \"30-day myocardial infarction\": \"N/A\",\n        \"30-day stroke\": \"N/A\",\n        \"30-day heart failure readmission\": \"N/A\",\n        \"1-year all-cause mortality\": \"N/A\",\n        \"1-year myocardial infarction\": \"N/A\",\n        \"1-year stroke\": \"N/A\",\n        \"1-year heart failure readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": \"N/A\",\n        \"PVL severity\": \"N/A\"\n    }\n}\n```",
        "usage_details": {
            "prompt_tokens": 5824,
            "completion_tokens": 1280,
            "total_tokens": 7104,
            "estimated_cost_usd": 0.0016416
        }
    }
}